Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer

The New York Times – Business:

In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.

Rebecca Robbins and Gina Kolata
Author: Rebecca Robbins and Gina Kolata

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins and Gina Kolata

in

Cancer, Clinical Trials, Deaths (Fatalities), Drugs (Pharmaceuticals), Food and Drug Administration, Pancreas, Pancreatic Cancer, Regulation and Deregulation of Industry, Sasse, Benjamin E, Tests (Medical)
←World’s biggest maker of condoms set to raise prices due to Iran war
Phone tracking shows how Colombian mercenaries backed Sudan’s RSF – report→

More posts

  • The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

  • Questions rise over primary polls following Michigan, Wisconsin upsets

  • Sevastopol blast kills Russian service member, state media says

  • Zero hours crackdown could cost firms up to £2.9bn a year

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube